{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T21:06:47Z","timestamp":1770498407768,"version":"3.49.0"},"reference-count":29,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2024,4,25]],"date-time":"2024-04-25T00:00:00Z","timestamp":1714003200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010001","name":"Health Resources and Services Administration (HRSA)","doi-asserted-by":"publisher","award":["U1EMC27863"],"award-info":[{"award-number":["U1EMC27863"]}],"id":[{"id":"10.13039\/100010001","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJERPH"],"abstract":"<jats:p>Sickle cell disease (SCD) is a group of chronic, genetic disorders of the red blood cells with significant gaps in access to evidence-based clinical care. Sickle Treatment and Outcomes Research in the Midwest (STORM), a provider network, utilized Project ECHO (Extension for Community Health Outcomes), a telementoring model, to deliver evidence-based education about SCD management. The purpose of this mixed-methods study is to evaluate the utility of Project ECHO as an educational strategy for healthcare providers treating children and adults with SCD. Annual evaluations were administered to STORM TeleECHO participants from 2016 to 2021. Survey data showed a statistically significant change in self-reported provider confidence in the ability to provide care for adult patients with SCD; identify suitable candidates for disease-modifying therapies; and confidence to prescribe disease-modifying therapies. Participants who attended at least 10 sessions were invited to participate in a semi-structured interview. Qualitative data were analyzed using thematic analysis and several themes emerged about the benefits, including (1) increased confidence, (2) integrated best-practice care, (3) connection to provider network and access to experts, (4) high-quality educational presentations and (5) opportunities for collaboration and a sense of community. This suggests that Project ECHO is accessible and leads to increased confidence in providers caring for individuals with SCD. Overall, participant knowledge gains successfully demonstrated the utility of Project ECHO as an educational resource for providers.<\/jats:p>","DOI":"10.3390\/ijerph21050530","type":"journal-article","created":{"date-parts":[[2024,4,26]],"date-time":"2024-04-26T05:13:41Z","timestamp":1714108421000},"page":"530","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["A Mixed-Methods Evaluation of a Project ECHO Program for the Evidence-Based Management of Sickle Cell Disease"],"prefix":"10.3390","volume":"21","author":[{"given":"Cami","family":"Mosley","sequence":"first","affiliation":[{"name":"Cincinnati Comprehensive Sickle Cell Center, Division of Hematology, Cincinnati Children\u2019s Hospital Medical Center, Cincinnati, OH 45229, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christina Bennett","family":"Farrell","sequence":"additional","affiliation":[{"name":"Cincinnati Comprehensive Sickle Cell Center, Division of Hematology, Cincinnati Children\u2019s Hospital Medical Center, Cincinnati, OH 45229, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles T.","family":"Quinn","sequence":"additional","affiliation":[{"name":"Cincinnati Comprehensive Sickle Cell Center, Division of Hematology, Cincinnati Children\u2019s Hospital Medical Center, Cincinnati, OH 45229, USA"},{"name":"Department of Pediatrics, College of Medicine, University of Cincinnati, Cincinnati, OH 45229, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9860-5467","authenticated-orcid":false,"given":"Lisa Marie","family":"Shook","sequence":"additional","affiliation":[{"name":"Cincinnati Comprehensive Sickle Cell Center, Division of Hematology, Cincinnati Children\u2019s Hospital Medical Center, Cincinnati, OH 45229, USA"},{"name":"Department of Pediatrics, College of Medicine, University of Cincinnati, Cincinnati, OH 45229, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2024,4,25]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/ajh.21570","article-title":"The number of people with sickle-cell disease in the United States: National and state estimates","volume":"85","author":"Brousseau","year":"2010","journal-title":"Am. J. Hematol."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"El-Haj, N., and Hoppe, C.C. (2018). Newborn screening for SCD in the USA and Canada. Int. J. Neonatal Screen., 4.","DOI":"10.3390\/ijns4040036"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1053\/j.semperi.2015.03.008","article-title":"Newborn screening for sickle cell diseases in the United States: A review of data spanning 2 decades","volume":"Volume 39","author":"Therrell","year":"2015","journal-title":"Seminars in Perinatology"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.blre.2013.09.001","article-title":"Management of sickle cell disease from childhood through adulthood","volume":"27","author":"Kanter","year":"2013","journal-title":"Blood Rev."},{"key":"ref_5","first-page":"1363","article-title":"Sickle cell disease in childhood: From newborn screening through transition to adult medical care","volume":"60","author":"Quinn","year":"2013","journal-title":"Pediatr. Clin."},{"key":"ref_6","first-page":"58","article-title":"An evidence-based approach to the treatment of adults with sickle cell disease","volume":"2005","author":"Lottenberg","year":"2005","journal-title":"ASH Educ. Program Book"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"853835","DOI":"10.1155\/2015\/853835","article-title":"Attitudes toward management of sickle cell disease and its complications: A national survey of academic family physicians","volume":"2015","author":"Mainous","year":"2015","journal-title":"Anemia"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1001\/jama.297.4.403","article-title":"Practice-based research\u2014\u201cBlue Highways\u201d on the NIH roadmap","volume":"297","author":"Westfall","year":"2007","journal-title":"JAMA"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1055\/s-0038-1637943","article-title":"Managing clinical knowledge for health care improvement","volume":"9","author":"Balas","year":"2000","journal-title":"Yearb. Med. Inform."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"3867","DOI":"10.1182\/bloodadvances.2019000916","article-title":"American Society of Hematology 2019 guidelines for sickle cell disease: Cardiopulmonary and kidney disease","volume":"3","author":"Liem","year":"2019","journal-title":"Blood Adv."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"S79","DOI":"10.1097\/j.pain.0000000000000824","article-title":"Sickle cell disease: A natural model of acute and chronic pain","volume":"158","author":"Brandow","year":"2017","journal-title":"Pain"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1182\/bloodadvances.2019001142","article-title":"American Society of Hematology 2020 guidelines for sickle cell disease: Prevention, diagnosis, and treatment of cerebrovascular disease in children and adults","volume":"4","author":"DeBaun","year":"2020","journal-title":"Blood Adv."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1182\/bloodadvances.2019001143","article-title":"American Society of Hematology 2020 guidelines for sickle cell disease: Transfusion support","volume":"4","author":"Chou","year":"2020","journal-title":"Blood Adv."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"3668","DOI":"10.1182\/bloodadvances.2021004394C","article-title":"American Society of Hematology 2021 guidelines for sickle cell disease: Stem cell transplantation","volume":"5","author":"Kanter","year":"2021","journal-title":"Blood Adv."},{"key":"ref_15","first-page":"1069","article-title":"Management of sickle cell disease: Recommendations from the 2014 expert panel report","volume":"92","author":"Yawn","year":"2015","journal-title":"Am. Fam. Physician"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Migotsky, M., Beestrum, M., and Badawy, S.M. (2022). Recent advances in sickle-cell disease therapies: A review of voxelotor, crizanlizumab, and L-glutamine. Pharmacy, 10.","DOI":"10.3390\/pharmacy10050123"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1002\/pbc.25608","article-title":"Survival among children and adults with sickle cell disease in Belgium: Benefit from hydroxyurea treatment","volume":"62","author":"Gulbis","year":"2015","journal-title":"Pediatr. Blood Cancer"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1353\/hpu.0.0272","article-title":"Examining the effectiveness of hydroxyurea in people with sickle cell disease","volume":"21","author":"Lanzkron","year":"2010","journal-title":"J. Health Care Poor Underserved"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1001\/jama.2015.3075","article-title":"Proportion of adults with sickle cell anemia and pain crises receiving hydroxyurea","volume":"313","author":"Stettler","year":"2015","journal-title":"JAMA"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"33616","DOI":"10.3402\/meo.v21.33616","article-title":"Translating sickle cell guidelines into practice for primary care providers with Project ECHO","volume":"21","author":"Shook","year":"2016","journal-title":"Med. Educ. Online"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1097\/ACM.0b013e31802d8f68","article-title":"Academic health center management of chronic diseases through knowledge networks: Project ECHO","volume":"82","author":"Arora","year":"2007","journal-title":"Acad. Med. J. Assoc. Am. Med. Coll."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1056\/NEJMoa1009370","article-title":"Outcomes of treatment for hepatitis C virus infection by primary care providers","volume":"364","author":"Arora","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1097\/ACM.0000000000000051","article-title":"Demonopolizing medical knowledge","volume":"89","author":"Arora","year":"2014","journal-title":"Acad. Med."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1002\/chp.21210","article-title":"Innovative telementoring for pain management: Project ECHO pain","volume":"34","author":"Katzman","year":"2014","journal-title":"J. Contin. Educ. Health Prof."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1353\/hpu.2013.0093","article-title":"Project ECHO: Replicating a novel model to enhance access to hepatitis C care in a community health center","volume":"24","author":"Khatri","year":"2013","journal-title":"J. Health Care Poor Underserved"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1007\/s11914-019-00543-9","article-title":"Bone health TeleECHO: A force multiplier to improve the care of skeletal diseases in underserved communities","volume":"17","author":"Lewiecki","year":"2019","journal-title":"Curr. Osteoporos. Rep."},{"key":"ref_27","unstructured":"Woolson, R.F. (2007). Wiley Encyclopedia of Clinical Trials, Wiley Online Library."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Krippendorff, K. (2018). Content Analysis: An Introduction to Its Methodology, Sage Publications.","DOI":"10.4135\/9781071878781"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/S2352-4642(23)00201-8","article-title":"The evolving treatment landscape for children with sickle cell disease","volume":"7","author":"Jacob","year":"2023","journal-title":"Lancet Child Adolesc. Health"}],"container-title":["International Journal of Environmental Research and Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1660-4601\/21\/5\/530\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T14:33:52Z","timestamp":1760106832000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1660-4601\/21\/5\/530"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,25]]},"references-count":29,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2024,5]]}},"alternative-id":["ijerph21050530"],"URL":"https:\/\/doi.org\/10.3390\/ijerph21050530","relation":{},"ISSN":["1660-4601"],"issn-type":[{"value":"1660-4601","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,25]]}}}